| Organometallic anticancer complexes of lapachol: metal centre-dependent formation of reactive oxygen species and correlation with cytotoxicity W Kandioller, E Balsano, SM Meier, U Jungwirth, S Göschl, A Roller, ... Chemical communications 49 (32), 3348-3350, 2013 | 159 | 2013 |
| Structure–Activity Relationships of Targeted RuII(η6-p-Cymene) Anticancer Complexes with Flavonol-Derived Ligands A Kurzwernhart, W Kandioller, S Bächler, C Bartel, S Martic, ... Journal of Medicinal Chemistry 55 (23), 10512-10522, 2012 | 157 | 2012 |
| Targeting the DNA-topoisomerase complex in a double-strike approach with a topoisomerase inhibiting moiety and covalent DNA binder A Kurzwernhart, W Kandioller, C Bartel, S Bächler, R Trondl, ... Chemical communications 48 (40), 4839-4841, 2012 | 155 | 2012 |
| Maltol‐Derived Ruthenium–Cymene Complexes with Tumor Inhibiting Properties: The Impact of Ligand–Metal Bond Stability on Anticancer Activity In Vitro W Kandioller, CG Hartinger, AA Nazarov, C Bartel, M Skocic, MA Jakupec, ... Chemistry–A European Journal 15 (45), 12283-12291, 2009 | 137 | 2009 |
| Physicochemical Studies and Anticancer Potency of Ruthenium η6-p-Cymene Complexes Containing Antibacterial Quinolones J Kljun, AK Bytzek, W Kandioller, C Bartel, MA Jakupec, CG Hartinger, ... Organometallics 30 (9), 2506-2512, 2011 | 136 | 2011 |
| Pyrone derivatives and metals: From natural products to metal-based drugs W Kandioller, A Kurzwernhart, M Hanif, SM Meier, H Henke, BK Keppler, ... Journal of Organometallic Chemistry 696 (5), 999-1010, 2011 | 121 | 2011 |
| Is the Reactivity of M(II)−Arene Complexes of 3-Hydroxy-2(1H)-pyridones to Biomolecules the Anticancer Activity Determining Parameter? M Hanif, H Henke, SM Meier, S Martic, M Labib, W Kandioller, ... Inorganic Chemistry 49 (17), 7953-7963, 2010 | 118 | 2010 |
| From Pyrone to Thiopyrone Ligands− Rendering Maltol-Derived Ruthenium (II)− Arene Complexes That Are Anticancer Active in Vitro W Kandioller, CG Hartinger, AA Nazarov, ML Kuznetsov, RO John, ... Organometallics 28 (15), 4249-4251, 2009 | 104 | 2009 |
| Task-specific thioglycolate ionic liquids for heavy metal extraction: synthesis, extraction efficacies and recycling properties S Platzer, M Kar, R Leyma, S Chib, A Roller, F Jirsa, R Krachler, ... Journal of hazardous materials 324, 241-249, 2017 | 101 | 2017 |
| Osmium (II)–versus ruthenium (II)–arene carbohydrate-based anticancer compounds: similarities and differences M Hanif, AA Nazarov, CG Hartinger, W Kandioller, MA Jakupec, VB Arion, ... Dalton Transactions 39 (31), 7345-7352, 2010 | 100 | 2010 |
| Novel thiosalicylate-based ionic liquids for heavy metal extractions R Leyma, S Platzer, F Jirsa, W Kandioller, R Krachler, BK Keppler Journal of hazardous materials 314, 164-171, 2016 | 98 | 2016 |
| Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: Synthesis, solution speciation and bioactivity O Dömötör, S Aicher, M Schmidlehner, MS Novak, A Roller, MA Jakupec, ... Journal of Inorganic Biochemistry 134, 57-65, 2014 | 87 | 2014 |
| 3-Hydroxyflavones vs. 3-hydroxyquinolinones: structure–activity relationships and stability studies on Ru II (arene) anticancer complexes with biologically active ligands A Kurzwernhart, W Kandioller, ÉA Enyedy, M Novak, MA Jakupec, ... Dalton Transactions 42 (17), 6193-6202, 2013 | 86 | 2013 |
| Synthesis and biological evaluation of the thionated antibacterial agent nalidixic acid and its organoruthenium (II) complex R Hudej, J Kljun, W Kandioller, U Repnik, B Turk, CG Hartinger, ... Organometallics 31 (16), 5867-5874, 2012 | 78 | 2012 |
| Tuning the anticancer activity of maltol-derived ruthenium complexes by derivatization of the 3-hydroxy-4-pyrone moiety W Kandioller, CG Hartinger, AA Nazarov, J Kasser, R John, MA Jakupec, ... Journal of Organometallic Chemistry 694 (6), 922-929, 2009 | 75 | 2009 |
| From hydrolytically labile to hydrolytically stable RuII–arene anticancer complexes with carbohydrate-derived co-ligands M Hanif, SM Meier, W Kandioller, A Bytzek, M Hejl, CG Hartinger, ... Journal of Inorganic Biochemistry 105 (2), 224-231, 2011 | 74 | 2011 |
| Improved reaction conditions for the synthesis of new NKP-1339 derivatives and preliminary investigations on their anticancer potential PS Kuhn, V Pichler, A Roller, M Hejl, MA Jakupec, W Kandioller, ... Dalton Transactions 44 (2), 659-668, 2015 | 70 | 2015 |
| Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugate SM Meier, M Novak, W Kandioller, MA Jakupec, VB Arion, ... Chemistry–A European Journal 19 (28), 9297-9307, 2013 | 69 | 2013 |
| Biomolecule binding vs. anticancer activity: reactions of Ru (arene)[(thio) pyr-(id) one] compounds with amino acids and proteins SM Meier, M Hanif, W Kandioller, BK Keppler, CG Hartinger Journal of Inorganic Biochemistry 108, 91-95, 2012 | 65 | 2012 |
| Modifying the structure of dinuclear ruthenium complexes with antitumor activity MG Mendoza‐Ferri, CG Hartinger, AA Nazarov, W Kandioller, K Severin, ... Applied Organometallic Chemistry 22 (6), 326-332, 2008 | 56 | 2008 |
